Diazide MR — New Gliclazide with Modified Release and Once Daily Dosing (Literature Review)

Abstract

This review deals with features of using gliclazide MR, in particular Diabeton MR and Diazide MR, in the treatment of patients with diabetes mellitus type 2. There is provided a detailed description of some gliclazide preparations. New formulation of gliclazide undoubtedly serve as a basis for the development of more effective antidiabetic agents.

Authors and Affiliations

O. O. Sergiyenko, V. O. Sergiyenko, L. M. Sergiyenko

Keywords

Related Articles

Impaired Glucose Homeostasis in Patients with Coronary Artery Disease: Changing Views for 40 Years

An analysis of two researches of the department spaced 40 years apart — «Diagnosis and treatment of latent forms of diabetes mellitus in coronary atherosclerosis in men» (Khaletskyi M.Ye., 1975) and «Peculiarities of the...

Diabetes mellitus: the role of genetic factors in the onset of the disease

This paper presents the analysis of the data of studies on the genetics of type 2 diabetes mellitus. High scientific quality papers of the recent years were used to prepare this work. The article deals with the role of s...

Prognostic Value of Proteolysis Indexes in the Formation of Diabetic Retinopathy

The article presents the results of the study on the violations in the proteolysis system of patients with type 2 diabetes mellitus (DM) and diabetic retinopathy (DR). We have evaluated the levels of matrix metalloprotei...

Download PDF file
  • EP ID EP226853
  • DOI -
  • Views 71
  • Downloads 0

How To Cite

O. O. Sergiyenko, V. O. Sergiyenko, L. M. Sergiyenko (2014). Diazide MR — New Gliclazide with Modified Release and Once Daily Dosing (Literature Review). Міжнародний ендокринологічний журнал, 2(58), 112-118. https://europub.co.uk/articles/-A-226853